CD86 and neoplasm: One study found that inducible IL-12 allowed CAR T cells to eradicate antigen-positive tumor cells and prevent outgrowth of antigen negative tumor cells by recruiting and activating macrophages to produce TNFα and upregulate costimulatory molecules CD80/CD86 to enhance T cell responses (127).